Sign in

CIK 0001540159

  • Non-accelerated filer
  • Smaller reporting company

Edesa Biotech, Inc.

Sign in to watch
Ticker
EDSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
British Columbia, Canada
Entity type
Operating
Phone
+1 905-475-1234
Business address
C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
Former names
Stellar Biotechnologies, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-03-17 Nijhawan Pardeep Chief Executive Officer Purchase +1,000 $1.83 $2K 2,120,024
2020-03-17 Nijhawan Pardeep Chief Executive Officer Purchase +1,000 $1.90 $2K 2,121,024
2020-01-08 van der Velden Peter Director Purchase +128,722 $3.20 $412K 1,833,066
2020-01-08 van der Velden Peter Director Purchase +11,903 $3.20 $38K 169,502
2020-01-08 Sistilli Carlo Director Purchase +2,436 $4.11 $10K 2,436
2020-01-08 JOHNSON LORIN K Director Purchase +8,524 $4.11 $35K 8,524
2020-01-08 Brooks Michael J President Purchase +1,827 $4.11 $8K 1,827

Page 3 of 3 · 47 trades